These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23579772)

  • 1. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep.
    Luján L; Pérez M; Salazar E; Álvarez N; Gimeno M; Pinczowski P; Irusta S; Santamaría J; Insausti N; Cortés Y; Figueras L; Cuartielles I; Vila M; Fantova E; Chapullé JL
    Immunol Res; 2013 Jul; 56(2-3):317-24. PubMed ID: 23579772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the bluetongue vaccination campaigns in sheep to overimmunization and ovine ASIA syndrome.
    Asín J; Pérez M; Pinczowski P; Gimeno M; Luján L
    Immunol Res; 2018 Dec; 66(6):777-782. PubMed ID: 30632098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.
    González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M
    Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Grimm L; Meilwes J; Punsmann T; Blaha I; Salditt A; Rohn K; Bastian M; Ganter M
    Vaccine; 2019 Sep; 37(39):5844-5853. PubMed ID: 31431410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only.
    Asín J; Pascual-Alonso M; Pinczowski P; Gimeno M; Pérez M; Muniesa A; de Pablo-Maiso L; de Blas I; Lacasta D; Fernández A; de Andrés D; Reina R; Luján L
    J Inorg Biochem; 2020 Feb; 203():110934. PubMed ID: 31783216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of virus-like particles for bluetongue disease.
    Roy P; French T; Erasmus BJ
    Vaccine; 1992; 10(1):28-32. PubMed ID: 1311487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
    Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
    Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
    Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
    J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.
    Mohamed DKA; Du J; Gao S; Tian Z; Zhang G; Huang D; Du R; Kang B; Liu G; Luo J; Yin H
    Vet Microbiol; 2018 Jun; 219():40-48. PubMed ID: 29778203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
    Hunter P; Modumo J
    Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of protective immunity after a single vaccination with a live attenuated bivalent bluetongue vaccine.
    Zhugunissov K; Yershebulov Z; Barakbayev K; Bulatov Y; Taranov D; Amanova Z; Abduraimov Y
    Vet Res Commun; 2015 Dec; 39(4):203-10. PubMed ID: 26280208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental bluetongue virus infection of sheep; effect of vaccination: pathologic, immunofluorescent, and ultrastructural studies.
    Mahrt CR; Osburn BI
    Am J Vet Res; 1986 Jun; 47(6):1198-203. PubMed ID: 3014927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.